News
1 minute read

MBHB Partner Kevin Noonan Authors DDN News Article Entitled, “Patent Docs: The CRISPR Chronicles”

McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D. authors a March 14, 2018 DDN News article entitled, “Patent Docs: The CRISPR chronicles”. CRISPR (an acronym for clustered regularly interspaced short palindromic repeats) is a technology derived from a bacterial immunity system for altering chromosomal sequences in situ in a cell in combination with a bacterially derived protein called Cas9, that is expected to have a game-changing effect on next-generation genetic engineering efforts in a wide variety of fields (hailed as the “Breakthrough of the Year” for 2015). view the article